Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Processing Intergenerational Trauma With Psilocybin-Assisted TherapyClinicalTrials.gov · 2026-08-13A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older AdultsClinicalTrials.gov · 2026-08-10Shrooming Ahead: How the U.S. is Marching Toward Psilocybin Legalization and What Other Countries May LearneYLS (Yale Law School) · 2026-07-30Surprising Variability in Tryptamine Profiles of Fruiting Bodies: Inter- and Intra-Strain Differences Across 14 Strains Cultivated Under Controlled Conditions.Journal of fungi (Basel, Switzerland) · 2026-07-02Anthracaurisin A─Discovery of a Cytotoxic -Sesquiterpene Dimer from Patagonian.Journal of natural products · 2026-06-26Multi-metric evaluations of acute psychedelic effects on fMRI brain entropy.Nature communications · 2026-06-24Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New MexicoFrontiers in Public Health · 2026-06-17THE PSYCHEDELIC AND KETAMINE RENAISSANCE IN THE FACE OF THE CRISIS IN MODERN PSYCHIATRYInternational Journal of Innovative Technologies in Social Science · 2026-06-14A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's DiseaseClinicalTrials.gov · 2026-06-08Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-12Human brain changes after first psilocybin useNature Communications · 2026-05-05A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary ExperimentsResearch Square · 2026-04-28Psilocybin acutely reduces low-frequency BOLD power and frequency-specific connectivitybioRxiv · 2026-04-13Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study ProtocolPsychoactives · 2026-04-13Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions.Biotechnology and bioengineering · 2026-04-01PSilocybin for psYCHological and existential distress in PALliative care (PSYCHED-PAL): A single arm unblinded clinical trial.Palliative medicine · 2026-04-01Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence.Exploratory research in clinical and social pharmacy · 2026-03-01Microdosing psilocybin and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trials.Neuropharmacology · 2026-02-15Cognitive and subjective effects of psilocybin microdosing: Results from two double-blind placebo-controlled longitudinal trials.Neuropharmacology · 2026-02-01Psychedelics distinctly alter brain entropy and complexity compared to psychostimulantsmedRxiv · 2026-01-16Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild StressJournal of Psychoactive Drugs · 2026-01-02Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal StudiesVCU Scholars Compass (Virginia Commonwealth University) · 2026-01-01Masking Influences: A Systematic Review of Placebo Control and Masking in Psychedelic Studies.Journal of psychoactive drugs · 2026-01-01Toward Standardized Products Containing Biomass of Psilocybe Cubensis Fungi.Journal of AOAC International · 2026-01-01Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.Palliative medicine · 2026-01-01Correction: Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2026-01-01Spiritual dimension and psychedelic experiences: A phenomenological approachPhilArchive · 2025-11-15Correction: Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational psychiatry · 2025-11-06Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric DisordersJournal of Pharma Insights and Research. · 2025-10-05Understanding psilocybin mushrooms and aiding in setting standards for a burgeoning industry in JamaicaPhytochemistry Letters · 2025-10-01Treatment with LSD and psilocybin at the department of psychiatry at Frederiksberg Hospital in Denmark from 1960 to 1973: an analysis of 324 cases.Nordic journal of psychiatry · 2025-10-01Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis.Translational psychiatry · 2025-08-29Intersecting Psychedelic Pharmacology and Gut-Brain Axis Signaling in Neurodegenerative DisordersJUNIOR RESEARCHERS · 2025-08-08Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology · 2025-07-01Molecular, haemodynamic and functional effects of LSD in the human brainmedRxiv · 2025-06-18Correction to: Unraveling psilocybin's therapeutic potential: behavioral and neuroplasticity insights in Wistar-Kyoto and Wistar male rat models of treatment-resistant depression.Psychopharmacology · 2025-06-01Neurochemical characterization of 5-HTR partial agonists with simultaneous PET-MRI.Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism · 2025-05-01Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.Palliative & supportive care · 2025-04-22Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic PropertiesJournal of Medicinal Chemistry · 2025-04-10High-quality draft genomes of ecologically and geographically diverse species.Microbiology resource announcements · 2025-02-11Crafting effective regulatory policies for psychedelics: What can be learned from the case of cannabis?Addiction (Abingdon, England) · 2025-02-01Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.Addiction (Abingdon, England) · 2025-01-30Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.Pharmaceuticals (Basel, Switzerland) · 2025-01-19Hallucinogen Usage, Experiencing Mystical Phenomena, and Transformational Identity ChangeJournal of International Crisis and Risk Communication Research · 2025-01-01Psilocybin alleviates high-glucose and high-lipid-induced skin aging in BJ5Ta fibroblasts.Biochemistry and cell biology = Biochimie et biologie cellulaire · 2025-01-01Characteristics and mental health of psychedelic mushroom and multi-psychedelic users relative to non-psychedelic users in American adults, 2020-2021.Frontiers in psychiatry · 2025-01-01Comparative Efficacy of Hallucinogens in Treating Mood Disorders Through a Meta-Analysis of Symptom Reduction, Dosage, and DurationJournal of International Crisis and Risk Communication Research · 2024-12-31Disentangling debate about therapeutic and recreational use of psychedelicsAddiction · 2024-12-15Neuroimaging of Serotonergic and Psychedelic Agonist Drug Challenges in Non-Human PrimatesProceedings on CD-ROM - International Society for Magnetic Resonance in Medicine. Scientific Meeting and Exhibition/Proceedings of the International Society for Magnetic Resonance in Medicine, Scientific Meeting and Exhibition · 2024-11-25Optimized psilocybin production in tryptophan catabolism-repressed fungi.Microbial biotechnology · 2024-11-01Psilocybin in pharmacotherapy of obsessive-compulsive disorder.Pharmacological reports: PR · 2024-10-01Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humansmedRxiv · 2024-09-22An estimate of the number of people with clinical depression eligible for psilocybin-assisted therapy in the United StatesPsychedelics. · 2024-09-13High Blood Pressure Among Psilocybin and Cannabis Consumers During the COVID-19 Pandemic: An Analysis of the COVID-19 Cannabis Health StudyDrug and Alcohol Dependence · 2024-07-01Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.Pharmacology & therapeutics · 2024-06-01Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseasesPharmacology & therapeutics · 2024-06-01From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream MedicineEuropean Journal of Arts Humanities and Social Sciences · 2024-05-01Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.Scientific reports · 2024-03-26Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometryJournal of Analytical Toxicology · 2024-03-01Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.Scientific reports · 2024-02-05Modern Psychedelic Microdosing Research on Mental Health: A Systematic Review.The primary care companion for CNS disorders · 2024-01-16Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2024-01-01Exploring the molecular basis of treatment-resistant depression: Discoveries from a rat model and psilocybin therapyNeuroscience Applied · 2024-01-01CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.Current neuropharmacology · 2024-01-01Amygdala response to emotional faces following acute administration of psilocybin in healthy individuals.Neuroscience applied · 2024-01-01Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results.Neuroscience and biobehavioral reviews · 2023-11-01Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.Scientific reports · 2023-10-14Use of Psychedelics for Pain: A Scoping Review.Anesthesiology · 2023-10-01Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.Molecular psychiatry · 2023-09-01In silico characterization of the psilocybin biosynthesis pathway.Computational biology and chemistry · 2023-06-01Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labellingNeuroscience Applied · 2023-01-01UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES.Psychiatria Danubina · 2023-01-01Classic psychedelics do not affect T cell and monocyte immune responses.Frontiers in psychiatry · 2023-01-01Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample.Frontiers in psychiatry · 2023-01-01Group psychedelic therapy: empirical estimates of cost-savings and improved access.Frontiers in psychiatry · 2023-01-01Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.The New England journal of medicine · 2022-11-03Molecular Structure, Reactivity and Spectroscopic Properties of Hallucinogens Psilocybin, Mescaline and their Derivatives - A Computational StudyLetters in Applied NanoBioScience · 2022-09-17Acute and long-term effects of psilocybin on energy balance and feeding behavior in mice.Translational psychiatry · 2022-08-11Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivitymedRxiv · 2022-07-10Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study.Psychopharmacology · 2022-06-01Effects of the 5-HT receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.Psychopharmacology · 2022-06-01Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.Journal of the neurological sciences · 2022-03-15Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulatory effects in healthy humansNeuroscience Applied · 2022-01-01Effects of psilocybin in relative and global cerebral blood flow and behavioural correlatesNeuroscience Applied · 2022-01-01Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study.Journal of psychopharmacology (Oxford, England) · 2022-01-01Music programming for psilocybin-assisted therapy: Guided Imagery and Music-informed perspectives.Frontiers in psychology · 2022-01-01The economics of psychedelic-assisted therapies: A research agenda.Frontiers in psychiatry · 2022-01-01Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experienceEuropean Neuropsychopharmacology · 2021-09-01Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-14Microdosing psychedelics and its effect on creativity: Lessons learned from three double-blind placebo controlled longitudinal trialsPsyArXiv · 2021-06-14Psilocybin-induced changes in brain network integrity and segregation correlate with plasma psilocin level and psychedelic experiencebioRxiv · 2021-02-05P.227 Psilocybin induces resting-state functional connectivity changes, which correlate with plasma psilocin levels and psychedelic experienceEuropean Neuropsychopharmacology · 2020-11-01Scalable Hybrid Synthetic/Biocatalytic Route to Psilocybin.Chemistry (Weinheim an der Bergstrasse, Germany) · 2020-07-02Drugs and the Music Industry: How the Neurological and Visual Effects of LSD and Psilocybin Impact Creativity and Songwriting AbilitiesVCU Scholars Compass (Virginia Commonwealth University) · 2020-01-01Psilocybin may help cancer patients with depression and anxiety for yearsAccess Science · 2020-01-01Structure Based Drug Design towards Exploring Potential Anti-Psychotic and Anti-Depressant Activity of Possible Stiff Base of PsilocybinSSRN Electronic Journal · 2019-12-29The effects of psilocybin microdosing on perception: a double-blind controlled studyOSF Preprints (OSF Preprints) · 2019-01-30Unlearning to See: Linking the Perceptual and Clinical Effects of Psychedelic Drugs.Cognitive Science · 2018-01-01Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study.Frontiers in psychology · 2018-01-01Mikrodosering av lysergsyradietylamid och psilocybin och dess effekter på psykisk hälsaKTH Publication Database DiVA (KTH Royal Institute of Technology) · 2017-12-31If you give a mouse a mushroom: Behavioral effects of hallucinogens in miceeScholarship (California Digital Library) · 2017-12-31LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.Nordic journal of psychiatry · 2017-10-01Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow.NeuroImage · 2017-10-01Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey.Journal of psychoactive drugs · 2015-01-01The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case seriesCephalalgia · 2010-03-26Other Times I Can Barely See: The Effects of Hallucinogens on Vision and AttentioneScholarship (California Digital Library) · 2009-12-31Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology · 2008-07-01Prepulse inhibition of the startle reflex and its attentional modulation in the human S-ketamine and N,N-dimethyltryptamine (DMT) models of psychosis.Journal of psychopharmacology (Oxford, England) · 2007-05-01Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.Pharmacopsychiatry · 2005-11-01Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosisPharmacopsychiatry · 2005-09-01Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans.Neuropsychobiology · 2002-01-01Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans.Behavioural pharmacology · 1998-11-01529 The hallucinogen psilocybin increases prepulse inhibition of the startle reflex in healthy humansInternational Journal of Psychophysiology · 1998-09-01Effects of psychodysleptic drug psilocybin on visual perception. Changes in brightness preference.Experientia · 1969-02-15Effects of excitatory and tranquilizing drugs on visual perception. Spatial distortion thresholds.Experientia · 1969-01-30Psilocybin-induced Autonomic, Perceptual, and Behavioral ChangePharmacopsychiatry · 1968-11-01PSILOCYBIN-INDUCED CHANGES IN PSYCHOLOGIC FUNCTION, ELECTROENCEPHALOGRAM, AND LIGHT-EVOKED POTENTIALS IN HUMAN SUBJECTSMayo Clinic Proceedings · 1968-03-01Psilocybin-induced changes in psychologic function, electroencephalogram, and light-evoked potentials in human subjects.Mayo Clinic proceedings · 1968-03-01A biosynthetic sequence from tryptophan to psilocybin.Tetrahedron letters · 1968-02-01